Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Morningside Healthcare Ltd, Unit C, Harcourt Way, Leicester, LE19 1WP, UK
Nidef 30 mg Prolonged Release Tablets.
Nifedipine Morningside 30 mg Prolonged Release Tablets.
| Pharmaceutical Form |
|---|
|
Pink coloured, film coated circular biconvex prolonged release tablets, having orifice on one side and plain on the other side. |
Each prolonged release tablet contains 30 mg nifedipine.
Each tablet contains a 10% overage of nifedipine to deliver the label claim.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nifedipine |
Nifedipine is a calcium antagonist of the 1,4-dihydropyridine type. Calcium antagonists reduce the transmembranal influx of calcium ions through the slow calcium channel into the cell. As a specific and potent calcium antagonist, nifedipine acts particularly on the cells of the myocardium and the smooth muscle cells of the coronary arteries and the peripheral resistance vessels. The main action of nifedipine is to relax arterial smooth muscle, both in the coronary and peripheral circulation. Nifedipine Tablets are formulated to achieve controlled delivery of nifedipine in a release profile sufficient to enable once-daily administration to be effective in clinical use. |
| List of Excipients |
|---|
|
Core: Polyethylene oxide Seal coating: Hypromellose (E464) Cellulose Acetate: Polyethylene glycol (E1521) Film coating: Hydroxypropyl cellulose (E463) |
PVC/PE/PVDC, Aluminium Blister. Blister packs of 10, 14, 15, 28, 30, 56, 60, 90 and 112 Prolonged Release Tablets.
Not all pack sizes may be marketed.
Morningside Healthcare Ltd, Unit C, Harcourt Way, Leicester, LE19 1WP, UK
PL 20117/0228
29/07/2013
| Drug | Countries | |
|---|---|---|
| NIDEF | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
